Login to Your Account

Earnings Roundup

EPO Threats Leveling off? Amgen Beats Q2 Estimates

By Jennifer Boggs

Monday, August 1, 2011
Like its fellow big biotechs, Amgen Inc. posted solid numbers for the second quarter. The Thousand Oaks, Calif.-based firm reported net income of $1.28 billion and earnings per share (EPS) of $1.37, well ahead of consensus estimates of $1.28 per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription